img

Global Veterinary Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Veterinary Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Veterinary Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Veterinary Vaccine market is projected to reach US$ 17260 million in 2034, increasing from US$ 10810 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2034. Demand from Farm Animal and Companion Animal are the major drivers for the industry.
Global veterinary vaccine key players include Merck, Zoetis, Boehringer Ingelheim, Ceva, and others. The top three producers together account for more than 60% of the market share, with Merck being the largest producer with approximately 25%. Global origins are mainly in North America, Europe, China, India, Latin America, South America, South Korea, Japan, Turkey, Middle East, Southeast Asia, etc. In terms of their products, live attenuated vaccines have the largest market share with a 50% share, followed by inactivated vaccines. In terms of its application, farm animals are the number one target, with a 70% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Veterinary Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
RVSRI
Medion
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other

Segment by Application


Farm Animal
Companion Animal

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Greece
Ukraine
Moldova
Albania
Serbia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Egypt
Each chapter of the report provides detailed information for readers to understand the Veterinary Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Veterinary Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Veterinary Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Veterinary Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Veterinary Vaccine introduction, etc. Veterinary Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Veterinary Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Veterinary Vaccine Market Overview
1.1 Veterinary Vaccine Product Overview
1.2 Veterinary Vaccine Market Segment by Type
1.2.1 Live Attenuated Vaccines
1.2.2 Inactivated Vaccines
1.2.3 Other
1.3 Global Veterinary Vaccine Market Size by Type
1.3.1 Global Veterinary Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Veterinary Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Veterinary Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Veterinary Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Veterinary Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Veterinary Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Type (2018-2024)
2 Global Veterinary Vaccine Market Competition by Company
2.1 Global Top Players by Veterinary Vaccine Sales (2018-2024)
2.2 Global Top Players by Veterinary Vaccine Revenue (2018-2024)
2.3 Global Top Players by Veterinary Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Veterinary Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Veterinary Vaccine Market Competitive Situation and Trends
2.5.1 Veterinary Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Veterinary Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Veterinary Vaccine Market
2.8 Key Manufacturers Veterinary Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Veterinary Vaccine Status and Outlook by Region
3.1 Global Veterinary Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Veterinary Vaccine Historic Market Size by Region
3.2.1 Global Veterinary Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Veterinary Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Veterinary Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Veterinary Vaccine Forecasted Market Size by Region
3.3.1 Global Veterinary Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Veterinary Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Veterinary Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Veterinary Vaccine by Application
4.1 Veterinary Vaccine Market Segment by Application
4.1.1 Farm Animal
4.1.2 Companion Animal
4.2 Global Veterinary Vaccine Market Size by Application
4.2.1 Global Veterinary Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Veterinary Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Veterinary Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Veterinary Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Veterinary Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Veterinary Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Veterinary Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Veterinary Vaccine Sales Breakdown by Application (2018-2024)
5 North America Veterinary Vaccine by Country
5.1 North America Veterinary Vaccine Historic Market Size by Country
5.1.1 North America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Veterinary Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Veterinary Vaccine Sales in Value by Country (2018-2024)
5.2 North America Veterinary Vaccine Forecasted Market Size by Country
5.2.1 North America Veterinary Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Veterinary Vaccine Sales in Value by Country (2024-2034)
6 Europe Veterinary Vaccine by Country
6.1 Europe Veterinary Vaccine Historic Market Size by Country
6.1.1 Europe Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Veterinary Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Veterinary Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Veterinary Vaccine Forecasted Market Size by Country
6.2.1 Europe Veterinary Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Veterinary Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Veterinary Vaccine by Region
7.1 Asia-Pacific Veterinary Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Veterinary Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Veterinary Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Veterinary Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Veterinary Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Veterinary Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Veterinary Vaccine Sales in Value by Region (2024-2034)
8 Latin America Veterinary Vaccine by Country
8.1 Latin America Veterinary Vaccine Historic Market Size by Country
8.1.1 Latin America Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Veterinary Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Veterinary Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Veterinary Vaccine Forecasted Market Size by Country
8.2.1 Latin America Veterinary Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Veterinary Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Veterinary Vaccine by Country
9.1 Middle East and Africa Veterinary Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Veterinary Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Veterinary Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Veterinary Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Veterinary Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Veterinary Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Veterinary Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Veterinary Vaccine Products Offered
10.1.5 Merck Recent Development
10.2 Zoetis
10.2.1 Zoetis Company Information
10.2.2 Zoetis Introduction and Business Overview
10.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Zoetis Veterinary Vaccine Products Offered
10.2.5 Zoetis Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Boehringer Ingelheim Veterinary Vaccine Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Ceva
10.4.1 Ceva Company Information
10.4.2 Ceva Introduction and Business Overview
10.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Ceva Veterinary Vaccine Products Offered
10.4.5 Ceva Recent Development
10.5 CAHIC
10.5.1 CAHIC Company Information
10.5.2 CAHIC Introduction and Business Overview
10.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 CAHIC Veterinary Vaccine Products Offered
10.5.5 CAHIC Recent Development
10.6 HVRI
10.6.1 HVRI Company Information
10.6.2 HVRI Introduction and Business Overview
10.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 HVRI Veterinary Vaccine Products Offered
10.6.5 HVRI Recent Development
10.7 Ringpu Biology
10.7.1 Ringpu Biology Company Information
10.7.2 Ringpu Biology Introduction and Business Overview
10.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Ringpu Biology Veterinary Vaccine Products Offered
10.7.5 Ringpu Biology Recent Development
10.8 Yebio
10.8.1 Yebio Company Information
10.8.2 Yebio Introduction and Business Overview
10.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Yebio Veterinary Vaccine Products Offered
10.8.5 Yebio Recent Development
10.9 DHN
10.9.1 DHN Company Information
10.9.2 DHN Introduction and Business Overview
10.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 DHN Veterinary Vaccine Products Offered
10.9.5 DHN Recent Development
10.10 WINSUN
10.10.1 WINSUN Company Information
10.10.2 WINSUN Introduction and Business Overview
10.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 WINSUN Veterinary Vaccine Products Offered
10.10.5 WINSUN Recent Development
10.11 Elanco
10.11.1 Elanco Company Information
10.11.2 Elanco Introduction and Business Overview
10.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Elanco Veterinary Vaccine Products Offered
10.11.5 Elanco Recent Development
10.12 Virbac
10.12.1 Virbac Company Information
10.12.2 Virbac Introduction and Business Overview
10.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Virbac Veterinary Vaccine Products Offered
10.12.5 Virbac Recent Development
10.13 Jinyu Bio-Technology
10.13.1 Jinyu Bio-Technology Company Information
10.13.2 Jinyu Bio-Technology Introduction and Business Overview
10.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Jinyu Bio-Technology Veterinary Vaccine Products Offered
10.13.5 Jinyu Bio-Technology Recent Development
10.14 ChengDu Tecbond
10.14.1 ChengDu Tecbond Company Information
10.14.2 ChengDu Tecbond Introduction and Business Overview
10.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.14.4 ChengDu Tecbond Veterinary Vaccine Products Offered
10.14.5 ChengDu Tecbond Recent Development
10.15 CAVAC
10.15.1 CAVAC Company Information
10.15.2 CAVAC Introduction and Business Overview
10.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.15.4 CAVAC Veterinary Vaccine Products Offered
10.15.5 CAVAC Recent Development
10.16 Kyoto Biken Laboratories
10.16.1 Kyoto Biken Laboratories Company Information
10.16.2 Kyoto Biken Laboratories Introduction and Business Overview
10.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Kyoto Biken Laboratories Veterinary Vaccine Products Offered
10.16.5 Kyoto Biken Laboratories Recent Development
10.17 FATRO
10.17.1 FATRO Company Information
10.17.2 FATRO Introduction and Business Overview
10.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.17.4 FATRO Veterinary Vaccine Products Offered
10.17.5 FATRO Recent Development
10.18 Vaksindo
10.18.1 Vaksindo Company Information
10.18.2 Vaksindo Introduction and Business Overview
10.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Vaksindo Veterinary Vaccine Products Offered
10.18.5 Vaksindo Recent Development
10.19 Bio-Labs
10.19.1 Bio-Labs Company Information
10.19.2 Bio-Labs Introduction and Business Overview
10.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Bio-Labs Veterinary Vaccine Products Offered
10.19.5 Bio-Labs Recent Development
10.20 Avimex Animal Health
10.20.1 Avimex Animal Health Company Information
10.20.2 Avimex Animal Health Introduction and Business Overview
10.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Avimex Animal Health Veterinary Vaccine Products Offered
10.20.5 Avimex Animal Health Recent Development
10.21 MEVAC
10.21.1 MEVAC Company Information
10.21.2 MEVAC Introduction and Business Overview
10.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.21.4 MEVAC Veterinary Vaccine Products Offered
10.21.5 MEVAC Recent Development
10.22 Biovac
10.22.1 Biovac Company Information
10.22.2 Biovac Introduction and Business Overview
10.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Biovac Veterinary Vaccine Products Offered
10.22.5 Biovac Recent Development
10.23 Atafen
10.23.1 Atafen Company Information
10.23.2 Atafen Introduction and Business Overview
10.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.23.4 Atafen Veterinary Vaccine Products Offered
10.23.5 Atafen Recent Development
10.24 Dyntec
10.24.1 Dyntec Company Information
10.24.2 Dyntec Introduction and Business Overview
10.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.24.4 Dyntec Veterinary Vaccine Products Offered
10.24.5 Dyntec Recent Development
10.25 RVSRI
10.25.1 RVSRI Company Information
10.25.2 RVSRI Introduction and Business Overview
10.25.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.25.4 RVSRI Veterinary Vaccine Products Offered
10.25.5 RVSRI Recent Development
10.26 Medion
10.26.1 Medion Company Information
10.26.2 Medion Introduction and Business Overview
10.26.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.26.4 Medion Veterinary Vaccine Products Offered
10.26.5 Medion Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Veterinary Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Veterinary Vaccine Industrial Chain Analysis
11.4 Veterinary Vaccine Market Dynamics
11.4.1 Veterinary Vaccine Industry Trends
11.4.2 Veterinary Vaccine Market Drivers
11.4.3 Veterinary Vaccine Market Challenges
11.4.4 Veterinary Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Veterinary Vaccine Distributors
12.3 Veterinary Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live Attenuated Vaccines
Table 2. Major Company of Inactivated Vaccines
Table 3. Major Company of Other
Table 4. Global Veterinary Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Veterinary Vaccine Sales by Type (2018-2024) & (M Doses)
Table 6. Global Veterinary Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Veterinary Vaccine Sales by Type (2018-2024) & (US& Million)
Table 8. Global Veterinary Vaccine Market Share in Value by Type (2018-2024)
Table 9. Global Veterinary Vaccine Price by Type (2018-2024) & (USD/K Doses)
Table 10. Global Veterinary Vaccine Sales by Type (2024-2034) & (M Doses)
Table 11. Global Veterinary Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Veterinary Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Veterinary Vaccine Sales Market Share in Value by Type (2024-2034)
Table 14. Global Veterinary Vaccine Price by Type (2024-2034) & (USD/K Doses)
Table 15. North America Veterinary Vaccine Sales by Type (2018-2024) & (M Doses)
Table 16. North America Veterinary Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Veterinary Vaccine Sales (M Doses) by Type (2018-2024)
Table 18. Europe Veterinary Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Veterinary Vaccine Sales (M Doses) by Type (2018-2024)
Table 20. Asia-Pacific Veterinary Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Veterinary Vaccine Sales (M Doses) by Type (2018-2024)
Table 22. Latin America Veterinary Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Veterinary Vaccine Sales (M Doses) by Type (2018-2024)
Table 24. Middle East and Africa Veterinary Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Veterinary Vaccine Sales by Company (2018-2024) & (M Doses)
Table 26. Global Veterinary Vaccine Sales Share by Company (2018-2024)
Table 27. Global Veterinary Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Veterinary Vaccine Revenue Share by Company (2018-2024)
Table 29. Global Market Veterinary Vaccine Price by Company (2018-2024) & (USD/K Doses)
Table 30. Global Veterinary Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Veterinary Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2022)
Table 33. Date of Key Manufacturers Enter into Veterinary Vaccine Market
Table 34. Key Manufacturers Veterinary Vaccine Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Veterinary Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Veterinary Vaccine Sales by Region (2018-2024) & (M Doses)
Table 38. Global Veterinary Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Veterinary Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Veterinary Vaccine Sales Market Share in Value by Region (2018-2024)
Table 41. Global Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 42. Global Veterinary Vaccine Sales by Region (2024-2034) & (M Doses)
Table 43. Global Veterinary Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Veterinary Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Veterinary Vaccine Sales Market Share in Value by Region (2024-2034)
Table 46. Global Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2024-2034)
Table 47. Global Veterinary Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Veterinary Vaccine Sales by Application (2018-2024) & (M Doses)
Table 49. Global Veterinary Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Veterinary Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Veterinary Vaccine Sales Market Share in Value by Application (2018-2024)
Table 52. Global Veterinary Vaccine Price by Application (2018-2024) & (USD/K Doses)
Table 53. Global Veterinary Vaccine Sales by Application (2024-2034) & (M Doses)
Table 54. Global Veterinary Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Veterinary Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Veterinary Vaccine Sales Market Share in Value by Application (2024-2034)
Table 57. Global Veterinary Vaccine Price by Application (2024-2034) & (USD/K Doses)
Table 58. North America Veterinary Vaccine Sales by Application (2018-2024) (M Doses)
Table 59. North America Veterinary Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Veterinary Vaccine Sales by Application (2018-2024) (M Doses)
Table 61. Europe Veterinary Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Veterinary Vaccine Sales by Application (2018-2024) (M Doses)
Table 63. Asia-Pacific Veterinary Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Veterinary Vaccine Sales by Application (2018-2024) (M Doses)
Table 65. Latin America Veterinary Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Veterinary Vaccine Sales by Application (2018-2024) (M Doses)
Table 67. Middle East and Africa Veterinary Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Veterinary Vaccine Sales by Country (2018-2024) & (M Doses)
Table 69. North America Veterinary Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Veterinary Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Veterinary Vaccine Sales Market Share in Value by Country (2018-2024)
Table 72. North America Veterinary Vaccine Sales by Country (2024-2034) & (M Doses)
Table 73. North America Veterinary Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Veterinary Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Veterinary Vaccine Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Veterinary Vaccine Sales by Country (2018-2024) & (M Doses)
Table 77. Europe Veterinary Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Veterinary Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Veterinary Vaccine Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Veterinary Vaccine Sales by Country (2024-2034) & (M Doses)
Table 81. Europe Veterinary Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Veterinary Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Veterinary Vaccine Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Veterinary Vaccine Sales by Region (2018-2024) & (M Doses)
Table 85. Asia-Pacific Veterinary Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Veterinary Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Veterinary Vaccine Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Veterinary Vaccine Sales by Region (2024-2034) & (M Doses)
Table 89. Asia-Pacific Veterinary Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Veterinary Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Veterinary Vaccine Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Veterinary Vaccine Sales by Country (2018-2024) & (M Doses)
Table 93. Latin America Veterinary Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Veterinary Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Veterinary Vaccine Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Veterinary Vaccine Sales by Country (2024-2034) & (M Doses)
Table 97. Latin America Veterinary Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Veterinary Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Veterinary Vaccine Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Veterinary Vaccine Sales by Country (2018-2024) & (M Doses)
Table 101. Middle East and Africa Veterinary Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Veterinary Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Veterinary Vaccine Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Veterinary Vaccine Sales by Country (2024-2034) & (M Doses)
Table 105. Middle East and Africa Veterinary Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Veterinary Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Veterinary Vaccine Sales Market Share in Value by Country (2024-2034)
Table 108. Merck Company Information
Table 109. Merck Introduction and Business Overview
Table 110. Merck Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 111. Merck Veterinary Vaccine Product
Table 112. Merck Recent Development
Table 113. Zoetis Company Information
Table 114. Zoetis Introduction and Business Overview
Table 115. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 116. Zoetis Veterinary Vaccine Product
Table 117. Zoetis Recent Development
Table 118. Boehringer Ingelheim Company Information
Table 119. Boehringer Ingelheim Introduction and Business Overview
Table 120. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 121. Boehringer Ingelheim Veterinary Vaccine Product
Table 122. Boehringer Ingelheim Recent Development
Table 123. Ceva Company Information
Table 124. Ceva Introduction and Business Overview
Table 125. Ceva Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 126. Ceva Veterinary Vaccine Product
Table 127. Ceva Recent Development
Table 128. CAHIC Company Information
Table 129. CAHIC Introduction and Business Overview
Table 130. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 131. CAHIC Veterinary Vaccine Product
Table 132. CAHIC Recent Development
Table 133. HVRI Company Information
Table 134. HVRI Introduction and Business Overview
Table 135. HVRI Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 136. HVRI Veterinary Vaccine Product
Table 137. HVRI Recent Development
Table 138. Ringpu Biology Company Information
Table 139. Ringpu Biology Introduction and Business Overview
Table 140. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 141. Ringpu Biology Veterinary Vaccine Product
Table 142. Ringpu Biology Recent Development
Table 143. Yebio Company Information
Table 144. Yebio Introduction and Business Overview
Table 145. Yebio Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 146. Yebio Veterinary Vaccine Product
Table 147. Yebio Recent Development
Table 148. DHN Company Information
Table 149. DHN Introduction and Business Overview
Table 150. DHN Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 151. DHN Veterinary Vaccine Product
Table 152. DHN Recent Development
Table 153. WINSUN Company Information
Table 154. WINSUN Introduction and Business Overview
Table 155. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 156. WINSUN Veterinary Vaccine Product
Table 157. WINSUN Recent Development
Table 158. Elanco Company Information
Table 159. Elanco Introduction and Business Overview
Table 160. Elanco Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 161. Elanco Veterinary Vaccine Product
Table 162. Elanco Recent Development
Table 163. Virbac Company Information
Table 164. Virbac Introduction and Business Overview
Table 165. Virbac Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 166. Virbac Veterinary Vaccine Product
Table 167. Virbac Recent Development
Table 168. Jinyu Bio-Technology Company Information
Table 169. Jinyu Bio-Technology Introduction and Business Overview
Table 170. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 171. Jinyu Bio-Technology Veterinary Vaccine Product
Table 172. Jinyu Bio-Technology Recent Development
Table 173. ChengDu Tecbond Company Information
Table 174. ChengDu Tecbond Introduction and Business Overview
Table 175. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 176. ChengDu Tecbond Veterinary Vaccine Product
Table 177. ChengDu Tecbond Recent Development
Table 178. CAVAC Company Information
Table 179. CAVAC Introduction and Business Overview
Table 180. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 181. CAVAC Veterinary Vaccine Product
Table 182. CAVAC Recent Development
Table 183. Kyoto Biken Laboratories Company Information
Table 184. Kyoto Biken Laboratories Introduction and Business Overview
Table 185. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 186. Kyoto Biken Laboratories Veterinary Vaccine Product
Table 187. Kyoto Biken Laboratories Recent Development
Table 188. FATRO Company Information
Table 189. FATRO Introduction and Business Overview
Table 190. FATRO Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 191. FATRO Veterinary Vaccine Product
Table 192. FATRO Recent Development
Table 193. Vaksindo Company Information
Table 194. Vaksindo Introduction and Business Overview
Table 195. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 196. Vaksindo Veterinary Vaccine Product
Table 197. Vaksindo Recent Development
Table 198. Bio-Labs Company Information
Table 199. Bio-Labs Introduction and Business Overview
Table 200. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 201. Bio-Labs Veterinary Vaccine Product
Table 202. Bio-Labs Recent Development
Table 203. Avimex Animal Health Company Information
Table 204. Avimex Animal Health Introduction and Business Overview
Table 205. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 206. Avimex Animal Health Veterinary Vaccine Product
Table 207. Avimex Animal Health Recent Development
Table 208. MEVAC Company Information
Table 209. MEVAC Introduction and Business Overview
Table 210. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 211. MEVAC Veterinary Vaccine Product
Table 212. MEVAC Recent Development
Table 213. Biovac Company Information
Table 214. Biovac Introduction and Business Overview
Table 215. Biovac Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 216. Biovac Veterinary Vaccine Product
Table 217. Biovac Recent Development
Table 218. Atafen Company Information
Table 219. Atafen Introduction and Business Overview
Table 220. Atafen Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 221. Atafen Veterinary Vaccine Product
Table 222. Atafen Recent Development
Table 223. Dyntec Company Information
Table 224. Dyntec Introduction and Business Overview
Table 225. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 226. Dyntec Veterinary Vaccine Product
Table 227. Dyntec Recent Development
Table 228. RVSRI Introduction and Business Overview
Table 229. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 230. RVSRI Veterinary Vaccine Product
Table 231. RVSRI Recent Development
Table 232. RVSRI Company Information
Table 233. Medion Company Information
Table 234. Medion Introduction and Business Overview
Table 235. Medion Veterinary Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 236. Medion Veterinary Vaccine Product
Table 237. Medion Recent Development
Table 238. Key Raw Materials Lists
Table 239. Raw Materials Key Suppliers Lists
Table 240. Veterinary Vaccine Market Trends
Table 241. Veterinary Vaccine Market Drivers
Table 242. Veterinary Vaccine Market Challenges
Table 243. Veterinary Vaccine Market Restraints
Table 244. Veterinary Vaccine Distributors List
Table 245. Veterinary Vaccine Downstream Customers
Table 246. Research Programs/Design for This Report
Table 247. Key Data Information from Secondary Sources
Table 248. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Vaccine Product Picture
Figure 2. Global Veterinary Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Veterinary Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Veterinary Vaccine Sales Status and Outlook (2018-2034) & (M Doses)
Figure 5. Product Picture of Live Attenuated Vaccines
Figure 6. Global Live Attenuated Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 7. Product Picture of Inactivated Vaccines
Figure 8. Global Inactivated Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 9. Product Picture of Other
Figure 10. Global Other Sales YoY Growth (2018-2034) & (M Doses)
Figure 11. Global Veterinary Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Veterinary Vaccine Sales Market Share by Type in 2022 & 2034
Figure 13. North America Veterinary Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. North America Veterinary Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Europe Veterinary Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Europe Veterinary Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Veterinary Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Veterinary Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Latin America Veterinary Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Veterinary Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Veterinary Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Veterinary Vaccine Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Vaccine Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Vaccine Revenue in 2022
Figure 25. Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Farm Animal
Figure 27. Global Farm Animal Sales YoY Growth (2018-2034) & (M Doses)
Figure 28. Product Picture of Companion Animal
Figure 29. Global Companion Animal Sales YoY Growth (2018-2034) & (M Doses)
Figure 30. Global Veterinary Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Veterinary Vaccine Sales Market Share by Application in 2022 & 2034
Figure 32. North America Veterinary Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. North America Veterinary Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Europe Veterinary Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Veterinary Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Veterinary Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Veterinary Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Veterinary Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Veterinary Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Veterinary Vaccine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Veterinary Vaccine Manufacturing Cost Structure
Figure 43. Veterinary Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed